LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 1694 | 11327 | 11103 | 1.0201 | 1.0147 |
MCF 10A | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 11024 | 11217 | 0.9829 | 0.9873 |
MCF 10A | GSK1059615 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 10702 | 11103 | 0.9639 | 0.9731 |
MCF 10A | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 9624 | 11217 | 0.8580 | 0.8908 |
MCF 10A | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 7368 | 11103 | 0.6637 | 0.7194 |
MCF 10A | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 6672 | 11217 | 0.5949 | 0.6530 |
MCF 10A | GSK1059615 | 1.11 | uM | LJP5 | 72 | hr | 1694 | 2596 | 11103 | 0.2339 | 0.1700 |
MCF 10A | GSK1059615 | 1.11 | uM | LJP6 | 72 | hr | 1694 | 3081 | 11217 | 0.2745 | 0.2424 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 1343 | 11103 | 0.1209 | -0.0842 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 2032 | 11217 | 0.1810 | 0.0663 |
MCF 10A | GSK1059615 | 10 | uM | LJP5 | 72 | hr | 1694 | 1469 | 11103 | 0.1323 | -0.0513 |
MCF 10A | GSK1059615 | 10 | uM | LJP6 | 72 | hr | 1694 | 1500 | 11217 | 0.1337 | -0.0462 |
MCF 10A | Brivanib | 0.04 | uM | LJP5 | 72 | hr | 1694 | 11133 | 11103 | 1.0027 | 1.0020 |
MCF 10A | Brivanib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 10774 | 11103 | 0.9704 | 0.9779 |
MCF 10A | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10776 | 11103 | 0.9705 | 0.9781 |
MCF 10A | Brivanib | 1.11 | uM | LJP5 | 72 | hr | 1694 | 9380 | 11103 | 0.8449 | 0.8794 |
MCF 10A | Brivanib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 7914 | 11103 | 0.7127 | 0.7651 |
MCF 10A | Brivanib | 10 | uM | LJP5 | 72 | hr | 1694 | 3918 | 11103 | 0.3529 | 0.3619 |
MCF 10A | CHIR-99021 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 11560 | 11217 | 1.0305 | 1.0221 |
MCF 10A | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 11662 | 11217 | 1.0398 | 1.0288 |
MCF 10A | CHIR-99021 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 11724 | 11217 | 1.0453 | 1.0327 |
MCF 10A | CHIR-99021 | 1.11 | uM | LJP6 | 72 | hr | 1694 | 11631 | 11217 | 1.0372 | 1.0267 |
MCF 10A | CHIR-99021 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 10634 | 11217 | 0.9480 | 0.9610 |
MCF 10A | CHIR-99021 | 10 | uM | LJP6 | 72 | hr | 1694 | 9109 | 11217 | 0.8119 | 0.8519 |
MCF 10A | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 1694 | 11701 | 11217 | 1.0431 | 1.0312 |